Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Patients with a certain diagnosis of cystic fibrosis and visited during normal clinical practice, in accordance with the standard operating procedures in force at the Centres.

• Both sexes

• Age \>18 years

• Obtaining informed consent for patients (based on the procedures established by the protocol).

Locations
Other Locations
Italy
Ospedale San Raffaele
RECRUITING
Milan
Contact Information
Primary
Nicola I Lorè, PhD
lore.nicolaivan@hsr.it
+390226434902
Time Frame
Start Date: 2021-04-08
Estimated Completion Date: 2027-03-30
Participants
Target number of participants: 40
Treatments
CF patients with chronic M. abscessus infection
CF patients with M. abscessus pulmonary disease
CF patients with no history of M. abscessus infection
Healty Controls
Related Therapeutic Areas
Sponsors
Leads: Ospedale San Raffaele
Collaborators: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

This content was sourced from clinicaltrials.gov